Diabetes drugs are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. The most common drugs used are insulin and oral medications.
This report aims to provide a comprehensive presentation of the global market for Diabetes Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Treatment Drugs. This report contains market size and forecasts of Diabetes Treatment Drugs in global, including the following market information:
Global Diabetes Treatment Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Diabetes Treatment Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Tablets Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Diabetes Treatment Drugs include Sanofi, Merck & Co., Novo Nordisk, Eli Lilly, Boehringer Ingelheim, Novartis, Johnson & Johnson, AstraZeneca and Takeda, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diabetes Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Treatment Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Diabetes Treatment Drugs Market Segment Percentages, by Type, 2022 (%)
Tablets
GLP-1
Insulin
Global Diabetes Treatment Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Diabetes Treatment Drugs Market Segment Percentages, by Application, 2022 (%)
Type 1 Diabetes
Type 2 Diabetes
Global Diabetes Treatment Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Diabetes Treatment Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetes Treatment Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Diabetes Treatment Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Merck & Co.
Novo Nordisk
Eli Lilly
Boehringer Ingelheim
Novartis
Johnson & Johnson
AstraZeneca
Takeda
Bayer
Tonghua DongBao
Hua Dong
Ganlee
Biocon
Outline of Major Chapters:
Chapter 1: Introduces the definition of Diabetes Treatment Drugs, market overview.
Chapter 2: Global Diabetes Treatment Drugs market size in revenue.
Chapter 3: Detailed analysis of Diabetes Treatment Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diabetes Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Diabetes Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diabetes Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Diabetes Treatment Drugs Overall Market Size
2.1 Global Diabetes Treatment Drugs Market Size: 2022 VS 2030
2.2 Global Diabetes Treatment Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Diabetes Treatment Drugs Players in Global Market
3.2 Top Global Diabetes Treatment Drugs Companies Ranked by Revenue
3.3 Global Diabetes Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Diabetes Treatment Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Diabetes Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetes Treatment Drugs Players in Global Market
3.6.1 List of Global Tier 1 Diabetes Treatment Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Diabetes Treatment Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Diabetes Treatment Drugs Market Size Markets, 2022 & 2030
4.1.2 Tablets
4.1.3 GLP-1
4.1.4 Insulin
4.2 By Type - Global Diabetes Treatment Drugs Revenue & Forecasts
4.2.1 By Type - Global Diabetes Treatment Drugs Revenue, 2018-2023
4.2.2 By Type - Global Diabetes Treatment Drugs Revenue, 2024-2030
4.2.3 By Type - Global Diabetes Treatment Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Diabetes Treatment Drugs Market Size, 2022 & 2030
5.1.2 Type 1 Diabetes
5.1.3 Type 2 Diabetes
5.2 By Application - Global Diabetes Treatment Drugs Revenue & Forecasts
5.2.1 By Application - Global Diabetes Treatment Drugs Revenue, 2018-2023
5.2.2 By Application - Global Diabetes Treatment Drugs Revenue, 2024-2030
5.2.3 By Application - Global Diabetes Treatment Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Diabetes Treatment Drugs Market Size, 2022 & 2030
6.2 By Region - Global Diabetes Treatment Drugs Revenue & Forecasts
6.2.1 By Region - Global Diabetes Treatment Drugs Revenue, 2018-2023
6.2.2 By Region - Global Diabetes Treatment Drugs Revenue, 2024-2030
6.2.3 By Region - Global Diabetes Treatment Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Diabetes Treatment Drugs Revenue, 2018-2030
6.3.2 US Diabetes Treatment Drugs Market Size, 2018-2030
6.3.3 Canada Diabetes Treatment Drugs Market Size, 2018-2030
6.3.4 Mexico Diabetes Treatment Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Diabetes Treatment Drugs Revenue, 2018-2030
6.4.2 Germany Diabetes Treatment Drugs Market Size, 2018-2030
6.4.3 France Diabetes Treatment Drugs Market Size, 2018-2030
6.4.4 U.K. Diabetes Treatment Drugs Market Size, 2018-2030
6.4.5 Italy Diabetes Treatment Drugs Market Size, 2018-2030
6.4.6 Russia Diabetes Treatment Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Diabetes Treatment Drugs Market Size, 2018-2030
6.4.8 Benelux Diabetes Treatment Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Diabetes Treatment Drugs Revenue, 2018-2030
6.5.2 China Diabetes Treatment Drugs Market Size, 2018-2030
6.5.3 Japan Diabetes Treatment Drugs Market Size, 2018-2030
6.5.4 South Korea Diabetes Treatment Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Diabetes Treatment Drugs Market Size, 2018-2030
6.5.6 India Diabetes Treatment Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Diabetes Treatment Drugs Revenue, 2018-2030
6.6.2 Brazil Diabetes Treatment Drugs Market Size, 2018-2030
6.6.3 Argentina Diabetes Treatment Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Diabetes Treatment Drugs Revenue, 2018-2030
6.7.2 Turkey Diabetes Treatment Drugs Market Size, 2018-2030
6.7.3 Israel Diabetes Treatment Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Diabetes Treatment Drugs Market Size, 2018-2030
6.7.5 UAE Diabetes Treatment Drugs Market Size, 2018-2030
7 Diabetes Treatment Drugs Companies Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Diabetes Treatment Drugs Major Product Offerings
7.1.4 Sanofi Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Merck & Co.
7.2.1 Merck & Co. Company Summary
7.2.2 Merck & Co. Business Overview
7.2.3 Merck & Co. Diabetes Treatment Drugs Major Product Offerings
7.2.4 Merck & Co. Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
7.2.5 Merck & Co. Key News & Latest Developments
7.3 Novo Nordisk
7.3.1 Novo Nordisk Company Summary
7.3.2 Novo Nordisk Business Overview
7.3.3 Novo Nordisk Diabetes Treatment Drugs Major Product Offerings
7.3.4 Novo Nordisk Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
7.3.5 Novo Nordisk Key News & Latest Developments
7.4 Eli Lilly
7.4.1 Eli Lilly Company Summary
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Diabetes Treatment Drugs Major Product Offerings
7.4.4 Eli Lilly Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
7.4.5 Eli Lilly Key News & Latest Developments
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Company Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Diabetes Treatment Drugs Major Product Offerings
7.5.4 Boehringer Ingelheim Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
7.5.5 Boehringer Ingelheim Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Diabetes Treatment Drugs Major Product Offerings
7.6.4 Novartis Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Diabetes Treatment Drugs Major Product Offerings
7.7.4 Johnson & Johnson Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
7.7.5 Johnson & Johnson Key News & Latest Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Company Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Diabetes Treatment Drugs Major Product Offerings
7.8.4 AstraZeneca Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
7.8.5 AstraZeneca Key News & Latest Developments
7.9 Takeda
7.9.1 Takeda Company Summary
7.9.2 Takeda Business Overview
7.9.3 Takeda Diabetes Treatment Drugs Major Product Offerings
7.9.4 Takeda Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
7.9.5 Takeda Key News & Latest Developments
7.10 Bayer
7.10.1 Bayer Company Summary
7.10.2 Bayer Business Overview
7.10.3 Bayer Diabetes Treatment Drugs Major Product Offerings
7.10.4 Bayer Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
7.10.5 Bayer Key News & Latest Developments
7.11 Tonghua DongBao
7.11.1 Tonghua DongBao Company Summary
7.11.2 Tonghua DongBao Business Overview
7.11.3 Tonghua DongBao Diabetes Treatment Drugs Major Product Offerings
7.11.4 Tonghua DongBao Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
7.11.5 Tonghua DongBao Key News & Latest Developments
7.12 Hua Dong
7.12.1 Hua Dong Company Summary
7.12.2 Hua Dong Business Overview
7.12.3 Hua Dong Diabetes Treatment Drugs Major Product Offerings
7.12.4 Hua Dong Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
7.12.5 Hua Dong Key News & Latest Developments
7.13 Ganlee
7.13.1 Ganlee Company Summary
7.13.2 Ganlee Business Overview
7.13.3 Ganlee Diabetes Treatment Drugs Major Product Offerings
7.13.4 Ganlee Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
7.13.5 Ganlee Key News & Latest Developments
7.14 Biocon
7.14.1 Biocon Company Summary
7.14.2 Biocon Business Overview
7.14.3 Biocon Diabetes Treatment Drugs Major Product Offerings
7.14.4 Biocon Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
7.14.5 Biocon Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Diabetes Treatment Drugs Market Opportunities & Trends in Global Market
Table 2. Diabetes Treatment Drugs Market Drivers in Global Market
Table 3. Diabetes Treatment Drugs Market Restraints in Global Market
Table 4. Key Players of Diabetes Treatment Drugs in Global Market
Table 5. Top Diabetes Treatment Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Diabetes Treatment Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Diabetes Treatment Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Diabetes Treatment Drugs Product Type
Table 9. List of Global Tier 1 Diabetes Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetes Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Diabetes Treatment Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Diabetes Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Diabetes Treatment Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Diabetes Treatment Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Diabetes Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Diabetes Treatment Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Diabetes Treatment Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Diabetes Treatment Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Diabetes Treatment Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Diabetes Treatment Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Diabetes Treatment Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Diabetes Treatment Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Diabetes Treatment Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Diabetes Treatment Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Sanofi Company Summary
Table 31. Sanofi Diabetes Treatment Drugs Product Offerings
Table 32. Sanofi Diabetes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Sanofi Key News & Latest Developments
Table 34. Merck & Co. Company Summary
Table 35. Merck & Co. Diabetes Treatment Drugs Product Offerings
Table 36. Merck & Co. Diabetes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Merck & Co. Key News & Latest Developments
Table 38. Novo Nordisk Company Summary
Table 39. Novo Nordisk Diabetes Treatment Drugs Product Offerings
Table 40. Novo Nordisk Diabetes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Novo Nordisk Key News & Latest Developments
Table 42. Eli Lilly Company Summary
Table 43. Eli Lilly Diabetes Treatment Drugs Product Offerings
Table 44. Eli Lilly Diabetes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Eli Lilly Key News & Latest Developments
Table 46. Boehringer Ingelheim Company Summary
Table 47. Boehringer Ingelheim Diabetes Treatment Drugs Product Offerings
Table 48. Boehringer Ingelheim Diabetes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Boehringer Ingelheim Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Diabetes Treatment Drugs Product Offerings
Table 52. Novartis Diabetes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. Johnson & Johnson Company Summary
Table 55. Johnson & Johnson Diabetes Treatment Drugs Product Offerings
Table 56. Johnson & Johnson Diabetes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Johnson & Johnson Key News & Latest Developments
Table 58. AstraZeneca Company Summary
Table 59. AstraZeneca Diabetes Treatment Drugs Product Offerings
Table 60. AstraZeneca Diabetes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. AstraZeneca Key News & Latest Developments
Table 62. Takeda Company Summary
Table 63. Takeda Diabetes Treatment Drugs Product Offerings
Table 64. Takeda Diabetes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Takeda Key News & Latest Developments
Table 66. Bayer Company Summary
Table 67. Bayer Diabetes Treatment Drugs Product Offerings
Table 68. Bayer Diabetes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Bayer Key News & Latest Developments
Table 70. Tonghua DongBao Company Summary
Table 71. Tonghua DongBao Diabetes Treatment Drugs Product Offerings
Table 72. Tonghua DongBao Diabetes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Tonghua DongBao Key News & Latest Developments
Table 74. Hua Dong Company Summary
Table 75. Hua Dong Diabetes Treatment Drugs Product Offerings
Table 76. Hua Dong Diabetes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Hua Dong Key News & Latest Developments
Table 78. Ganlee Company Summary
Table 79. Ganlee Diabetes Treatment Drugs Product Offerings
Table 80. Ganlee Diabetes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Ganlee Key News & Latest Developments
Table 82. Biocon Company Summary
Table 83. Biocon Diabetes Treatment Drugs Product Offerings
Table 84. Biocon Diabetes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Biocon Key News & Latest Developments
List of Figures
Figure 1. Diabetes Treatment Drugs Segment by Type in 2022
Figure 2. Diabetes Treatment Drugs Segment by Application in 2022
Figure 3. Global Diabetes Treatment Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Diabetes Treatment Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Diabetes Treatment Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetes Treatment Drugs Revenue in 2022
Figure 8. By Type - Global Diabetes Treatment Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Diabetes Treatment Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Diabetes Treatment Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Diabetes Treatment Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Diabetes Treatment Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Diabetes Treatment Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Diabetes Treatment Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Diabetes Treatment Drugs Revenue Market Share, 2018-2030
Figure 16. US Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Diabetes Treatment Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Diabetes Treatment Drugs Revenue Market Share, 2018-2030
Figure 28. China Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Diabetes Treatment Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Diabetes Treatment Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Diabetes Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Sanofi Diabetes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck & Co. Diabetes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novo Nordisk Diabetes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Eli Lilly Diabetes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Boehringer Ingelheim Diabetes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Novartis Diabetes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Johnson & Johnson Diabetes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. AstraZeneca Diabetes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Takeda Diabetes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bayer Diabetes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Tonghua DongBao Diabetes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Hua Dong Diabetes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Ganlee Diabetes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Biocon Diabetes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
